Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia aging study

被引:585
作者
Schmidt, R
Schmidt, H
Curb, JD
Masaki, K
White, LR
Launer, LJ
机构
[1] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA
[2] Karl Franzens Univ Graz, Dept Neurol, A-8010 Graz, Austria
[3] Karl Franzens Univ Graz, Inst Med Biochem & Med Mol Biol, A-8010 Graz, Austria
[4] Pacific Hlth Res Inst, Honolulu, HI USA
关键词
D O I
10.1002/ana.10265
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Inflammatory responses are associated with cardiovascular disease and may be associated with dementing disease. We evaluated the long-term prospective association between dementia and high-sensitivity C-reactive protein, a nonspecific marker of inflammation. Data are from the cohort of Japanese American men who were seen in the second examination of the Honolulu Heart Program (1968-1970) and subsequently were reexamined 25 years later for dementia in the Honolulu-Asia Aging Study (1991-1996). In a random subsample of 1,050 Honolulu-Asia Aging Study cases and noncases, high-sensitivity C-reactive protein concentrations were measured from serum taken at the second examination; dementia was assessed in a clinical examination that included neuroimaging and neuropsychological testing and was evaluated using international criteria. Compared with men in the lowest quartile (< 0.34mg/L) of high-sensitivity C-reactive protein, men in the upper three quartiles had a 3-fold significantly increased risk for all dementias combined, Alzheimer's disease, and vascular dementia. For vascular dementia, the risk increased with increasing quartile. These relations were independent of cardiovascular risk factors and disease. These data support the view that inflammatory markers may reflect not only peripheral disease, but also cerebral disease mechanisms related to dementia, and that these processes are measurable long before clinical symptoms appear.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 50 条
[1]   Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease [J].
Alvarez, XA ;
Franco, A ;
FernandezNovoa, L ;
Cacabelos, R .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 29 (2-3) :237-252
[2]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[3]   Frequency of stages of Alzheimer-related lesions in different age categories [J].
Braak, H ;
Braak, E .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :351-357
[4]  
Breslow NE, 1980, STAT METHODS CANC RE, P122
[5]   CRITERIA FOR THE DIAGNOSIS OF ISCHEMIC VASCULAR DEMENTIA PROPOSED BY THE STATE OF CALIFORNIA ALZHEIMERS-DISEASE-DIAGNOSTIC-AND-TREATMENT-CENTERS [J].
CHUI, HC ;
VICTOROFF, JI ;
MARGOLIN, D ;
JAGUST, W ;
SHANKLE, R ;
KATZMAN, R .
NEUROLOGY, 1992, 42 (03) :473-480
[6]   Systemic complement activation in ischemic stroke [J].
Di Napoli, M .
STROKE, 2001, 32 (06) :1444-1444
[7]   AN AUTOPSY STUDY OF THE INCIDENCE OF LACUNES IN RELATION TO AGE, HYPERTENSION, AND ARTERIOSCLEROSIS [J].
DOZONO, K ;
ISHII, N ;
NISHIHARA, Y ;
HORIE, A .
STROKE, 1991, 22 (08) :993-996
[8]   C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease [J].
Duong, TH ;
Nikolaeva, M ;
Acton, PJ .
BRAIN RESEARCH, 1997, 749 (01) :152-156
[9]   Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty [J].
Ershler, WB ;
Keller, ET .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :245-270
[10]   Cerebral microvascular pathology in aging and Alzheimer's disease [J].
Farkas, E ;
Luiten, PGM .
PROGRESS IN NEUROBIOLOGY, 2001, 64 (06) :575-611